ClinVar Miner

Submissions for variant NM_024422.6(DSC2):c.865C>T (p.Pro289Ser)

gnomAD frequency: 0.00002  dbSNP: rs200802591
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039443 SCV000063127 uncertain significance not specified 2010-12-14 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The Pro289Ser v ariant has been reported in one individual with possible ARVD/C and was absent f rom 300 ethnically matched control chromosomes (Bhuiyan 2009). Proline (Pro) at position 289 is conserved across in mammals (more distant species were not avail able. In addition, three computer programs (AlignGCGD, PolyPhen, SIFT) predict t he variant to significantly affect the protein?s function. While the absence fro m controls and the limited evolutionary conservation data available support a pa thogenic role, the number of controls tested is not high enough to exclude that the variant is benign. In summary, the significance of the Pro289Ser variant c annot be determined without additional studies.
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000608268 SCV000743497 uncertain significance Arrhythmogenic right ventricular dysplasia 11 2017-01-25 criteria provided, single submitter clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000608268 SCV000744768 uncertain significance Arrhythmogenic right ventricular dysplasia 11 2015-09-21 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001181113 SCV001346199 uncertain significance Cardiomyopathy 2022-12-21 criteria provided, single submitter clinical testing This missense variant replaces proline with serine at codon 289 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616) and in an individual affected with dilated cardiomyopathy (Verdonschot 2021, disertation, Maastricht University). This variant has also been identified in 8/282798 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Invitae RCV000608268 SCV001490121 uncertain significance Arrhythmogenic right ventricular dysplasia 11 2023-10-22 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 289 of the DSC2 protein (p.Pro289Ser). This variant is present in population databases (rs200802591, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616, 30847666, 32880476). ClinVar contains an entry for this variant (Variation ID: 46200). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DSC2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001552905 SCV001773679 uncertain significance not provided 2019-09-30 criteria provided, single submitter clinical testing Reported in one Dutch individual diagnosed with probable ARVC based on Task Force Criteria (Bhuiyan et al., 2009); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID#46200; Landrum et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32880476, 30847666, 20031616)
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000608268 SCV000733779 uncertain significance Arrhythmogenic right ventricular dysplasia 11 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV001552905 SCV001918893 uncertain significance not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV001552905 SCV001954078 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.